| Ytd | 63.34% | |
| 1y | 150.79% |
| Open | 41.05 | Prev Close | 41.06 | Low | 41.03 | High | 41.07 | Mkt Cap | 5.25B |
| Vol | 0.00 | Avg Vol | 6.37M | EPS | 1.07 | P/E | 38.35 | Forward P/E | 46.30 |
| Beta | -0.24 | Short Ratio | 1.15 | Inst. Own | 110.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 33.60 | 200-d Avg | 26.15 | 1yr Est | 40.92 |
APLS News
Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceutica
[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival
[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAP
NEW YORK, May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S
The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed
Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $0.15 per share, beating th
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & A
The Nasdaq Composite surged 15.3% in April, marking its strongest monthly gain since the early pande
Biogen beats Q1 earnings and revenue estimates, fueled by new drug growth, but cuts 2026 EPS outlook
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde a
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) have received an average re
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Apellis (NASDAQ: APLS) for
Apellis jumps as Biogen agrees $5.6 Billion acquisition, offering $41/share plus milestones, boostin
Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuti
Pre-Market Stock Futures: Risk-on appeared back, at least for the last two days, as the stock market
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) hit a new 52-week high duri
NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & As
BIIB's $5.6B offer to acquire APLS is set to add two key immunology drugs, boosting near-term revenu
Top Wall Street analysts changed their outlook on top names. For a complete view of all rating chang
Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. T
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell
Gold and silver surged to fresh record highs Monday as investors reassessed the Federal Reserve'
The S&P 500 pushed to fresh record highs during midday trading on Wednesday, extending a three-d
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announc
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs.
This morning 77 companies reached new 52-week highs.
Stocks That Hit 52-Week Lows On Wednesday